Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS??? EQUITY DEFICIT (Unaudited)

v3.19.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY DEFICIT (Unaudited) - USD ($)
Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Total
Balance at beginning at Dec. 31, 2017 $ 5,328 $ 8,281,793 $ (10,380,995) $ (2,093,874)
Balance at beginning (in shares) at Dec. 31, 2017 1 53,276,676      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Redeemable shares issued in conjunction with note payable $ 300 103,260 103,560
Redeemable shares issued in conjunction with note payable (in shares) 3,000,000      
issuance of common stock and warrants with short-term convertible notes $ 83 65,423 65,506
issuance of common stock and warrants with short-term convertible notes (in shares) 833,332      
Shares issued in conjunction with modification of note payable $ 240 263,282 263,522
Shares issued in conjunction with modification of note payable (in shares) 2,395,650      
Net loss (739,392) (739,392)
Balance at end at Mar. 31, 2018 $ 5,951 8,713,758 (11,120,387) (2,400,678)
Balance at end (in shares) at Mar. 31, 2018 1 59,505,658      
Balance at beginning at Dec. 31, 2018 $ 8,128 9,277,899 (13,001,269) (3,715,242)
Balance at beginning (in shares) at Dec. 31, 2018 1 81,272,408      
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss 53,960 53,960
Balance at end at Mar. 31, 2019 $ 8,128 $ 9,277,899 $ (12,947,309) $ (3,661,282)
Balance at end (in shares) at Mar. 31, 2019 2 81,272,408